JNJ-65234637   Click here for help

GtoPdb Ligand ID: 12414

Synonyms: compound 58 [PMID: 36793435] | JNJ65234637 | OICR-12694 | OICR12694
PDB Ligand
Compound class: Synthetic organic
Comment: JNJ-65234637 is an orally bioavailable, small molecule protein-protein interaction inhibitor, that disrupts the association between the B cell lymphoma 6 (BCL6) oncogenic transcription factor and its transcriptional co-repressor proteins [1]. Binds to BCL6's N-terminal BTB domain which is a crucial site for interactions with a number of co-repressor proteins. Dysregulated BCL6 drives several forms of non-Hodgkin lymphoma, making it a tractable therapeutic drug target.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 12
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 147.17
Molecular weight 645.03
XLogP 1.24
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1CN(C)CCN1C2=CC(=C(C(=N2)F)Cl)NC(=O)CN3C=C(C4=C(C(=C(C(=C4)C(=O)N)O)F)F)C5=C3N=C6CCCN6C5=O
Isomeric SMILES ClC=1C(=NC(=CC1NC(CN2C=C(C3=C2N=C4N(C3=O)CCC4)C=5C(=C(C(=C(C(=O)N)C5)O)F)F)=O)N6[C@H](CN(CC6)C)C)F
InChI InChI=1S/C29H28ClF3N8O4/c1-13-10-38(2)6-7-40(13)19-9-17(22(30)26(33)36-19)35-20(42)12-39-11-16(14-8-15(27(34)44)25(43)24(32)23(14)31)21-28(39)37-18-4-3-5-41(18)29(21)45/h8-9,11,13,43H,3-7,10,12H2,1-2H3,(H2,34,44)(H,35,36,42)/t13-/m0/s1
InChI Key LGAFZGSECXDYIR-ZDUSSCGKSA-N
Bioactivity Comments
JNJ-65234637 inhibits proliferation of diffuse large B-cell lymphoma (DLBCL) cells in vitro [1].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
BCL6 transcription repressor Hs Inhibitor Binding 8.3 pKd - 1
pKd 8.3 (Kd 5x10-9 M) [1]